Center for Translational Research Selects BioFortis Software
The Center for Translational Research, Towson, MD, part of CHI's Institute for Research and Innovation, will use Labmatrix software from BioFortis to manage its data and informatics.
"This software functions in a compliant and auditable way, and it will allow us to keep our specimen-based biomedical research data and patient-based clinical data together in one place," said Damon Hostin, director of business development and marketing for the Center for Translational Research. "That information technology capability is quite uncommon in the biomedical community, and it's essential to the success of the Center for Translational Research."
"We are excited to be working with BioFortis," said Jeffrey Otto, PhD, national director of the Center for Translational Research. "Their Labmatrix product has been tailored to the specific needs of the center and is designed to work seamlessly with CHI's market-based organizations. We are confident that the use of Labmatrix will help enable partnership opportunities within our hospital system."
Using Labmatrix, physicians and scientists can explore and ask complex questions about collected data, helping to deliver improved, personalized treatment options for patients. The software also ensures the security of patient information. "The market-based organizations that work with us can be confident that the CHI community will be able to make full use of data from these specimens, and that the data will be stored and retrieved in a way that is compliant with all regulations. In addition, patient information and identification will be fully protected," said Hostin.
Labmatrix also has the capability for future integration with CHI's electronic medical record system. For more information, contact Damon Hostin, firstname.lastname@example.org.